Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PYXS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Pyxis Oncology, Inc. as stock downgraded to Sell Candidate.
(Updated on May 10, 2024)

Sell candidate since May 10, 2024 PDF

The Pyxis Oncology, Inc. stock price fell by -3.77% on the last day (Friday, 10th May 2024) from $4.51 to $4.34. During the last trading day the stock fluctuated 5.57% from a day low at $4.31 to a day high of $4.55. The price has been going up and down for this period, and there has been a 0.93% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -198 thousand shares and in total, 229 thousand shares were bought and sold for approximately $993.73 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.91% during the next 3 months and, with a 90% probability hold a price between $2.40 and $4.51 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PYXS Signals & Forecast

There are mixed signals in the stock today. The Pyxis Oncology, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.37 and $4.61. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 4.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pyxis Oncology, Inc. stock

Pyxis Oncology, Inc. finds support from accumulated volume at $4.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.240 between high and low, or 5.57%. For the last week the stock has had daily average volatility of 6.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PYXS) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Pyxis Oncology, Inc. to open at $4.40, and during the day (based on 14 day Average True Range), to move between $3.96 and $4.72, which gives a possible trading interval of +/-$0.380 (+/-8.74%) up or down from last closing price. If Pyxis Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 17.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.20 (3.23%) than the resistance at $4.74 (9.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pyxis Oncology, Inc. stock A Buy?

Pyxis Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.043 Sell Candidate Downgraded

Predicted Opening Price for Pyxis Oncology, Inc. of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
$4.40 ( 1.38%) $4.34

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PYXS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.64 6.91 %
R2 4.55 4.80 %
R1 4.49 3.49 %
Current price: 4.34
Support S1 4.31 -0.730 %
S2 4.25 -2.04 %
S3 4.16 -4.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.96 14.29 %
R2 4.79 10.37 %
R1 4.74 9.22 %
Current price 4.34
Support S1 4.20 -3.23%
S2 3.99 -8.06%
S3 3.65 -15.90%

FAQ

What is the symbol for Pyxis Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Pyxis Oncology, Inc. is PYXS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pyxis Oncology, Inc. Stock?
Pyxis Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Pyxis Oncology, Inc. Stock?
Pyxis Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pyxis Oncology, Inc. Stock.

What's the current price of Pyxis Oncology, Inc. Stock?
As of the end of day on the May 10, 2024, the price of an Pyxis Oncology, Inc. (PYXS) share was $4.34.

What is the 52-week high and low for Pyxis Oncology, Inc. Stock?
The 52-week high for Pyxis Oncology, Inc. Stock is $6.85 and the 52-week low is $1.35.

What is the market capitalization of Pyxis Oncology, Inc. Stock?
As of the May 10, 2024, the market capitalization of Pyxis Oncology, Inc. is 262.182M.

When is the next earnings date for Pyxis Oncology, Inc.?
The upcoming earnings date for Pyxis Oncology, Inc. is Aug 11, 2024.
Click to get the best stock tips daily for free!

About Pyxis Oncology, Inc.

Pyxis Oncology. Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therap... PYXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT